# Spain Structural Heart Devices Market

> Spain Structural Heart Devices Market Research Report: Size, Share, Trend Analysis By Types (Heart Valve Devices, Annuloplasty Rings, Occluders, Delivery Systems), By Indication (Valvular Heart Disease, Cardiomyopathy) andBy Procedure (Replacement Procedures, Repair Procedures) - Growth Outlook & Industry Forecast 2025 To 2035

- **Forecast Period:** 2025 - 2035
- **CAGR:** 5.86%
- **2024:** $ 19.25 Million
- **2025:** $ 20.38 Million
- **2035:** $ 36 Million
- **Key Players:** Edwards Lifesciences (US), Medtronic (US), Abbott Laboratories (US), Boston Scientific (US), Cardinal Health (US), LivaNova (GB), Terumo Corporation (JP), JenaValve Technology (DE), AtriCure (US)

**Report ID:** MRFR/HC/55144-HCR · **Pages:** 200 · **Author:** Satyendra Maurya & Garvit Vyas · **Last Updated:** April 24, 2026

**URL:** https://www.marketresearchfuture.com/reports/spain-structural-heart-devices-market-56910

---

## Market Summary

## **Spain Structural Heart Devices Market Overview****:**

As per MRFR analysis, the Spain Structural Heart Devices Market Size was estimated at 17.89 (USD Million) in 2024.The Spain Structural Heart Devices Market Industry is expected to grow from 19(USD Million) in 2025 to 45 (USD Million) by 2035. The Spain Structural Heart Devices Market CAGR (growth rate) is expected to be around 8.154% during the forecast period (2025 - 2035).

### **Key Spain Structural Heart Devices Market Trends Highlighted**

The Spain Structural Heart Devices Market is witnessing significant transformation, driven by an aging population that presents a higher prevalence of cardiovascular diseases. With a robust healthcare infrastructure and government initiatives aimed at enhancing cardiac care, hospitals in Spain are increasingly adopting innovative structural heart devices. 

The growing awareness among healthcare professionals about advanced treatment options fuels demand for these devices, contributing to market expansion. Additionally, there is an opportunity for increased investment in research and development to explore personalized medicine approaches in cardiovascular care, as Spanish health authorities focus on improving patient outcomes through innovative technologies.The trend toward minimally invasive procedures is gaining traction, aligning with patients’ preference for quicker recovery times and reduced hospital stays. 

Hospitals and healthcare facilities are now integrating these advanced devices into routine practice, highlighting a shift towards patient-centered care. Recent regulatory support from Spanish health agencies has also paved the way for easier market entry for emerging technologies, allowing companies to introduce new products more swiftly. 

Collaboration between academia, industry, and government entities is becoming more pronounced, facilitating knowledge exchange and encouraging local manufacturing of structural heart devices.As partnerships grow, there is a clear shift towards localized innovations that cater specifically to the needs of the Spanish population. This collaborative environment fosters a dynamic marketplace ripe with opportunities amidst the evolving landscape of structural heart health.

Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review

## **Spain Structural Heart Devices Market Drivers**

### **Increasing Prevalence of Cardiovascular Diseases in Spain**

The increasing prevalence of cardiovascular diseases in Spain is a major driver for the Spain [Structural Heart Devices Market](../../../reports/structural-heart-devices-market-6385) Industry. According to the Spanish Society of Cardiology, cardiovascular diseases are responsible for approximately 30% of all deaths in Spain, making them the leading cause of mortality in the country. 

This rising trend necessitates advanced therapeutic solutions, effectively increasing the demand for structural heart devices.Significantly, the Ministry of Health in Spain has noted a sharp increase in heart problems among the elderly, forecasting a 45% rise in heart disease cases by the year 2030. This worrying figure underscores the growing demand for advanced heart innovations, which will subsequently increase the market for devices such as transcatheter aortic valve replacements and atrial septal defect closures.

### **Technological Advancements in Medical Devices**

Technological advancements are fundamentally shaping the Spain Structural Heart Devices Market Industry. The integration of minimally invasive procedures has made it possible for patients to undergo heart surgeries with less risk and faster recovery times. For example, the introduction of percutaneous aortic valve replacement has gained tremendous traction among healthcare providers in Spain. 

The Spanish Registry of Cardiac Interventions reported a 60% increase in such minimally invasive procedures in recent years.Many prominent medical device companies, such as Medtronic and Edwards Lifesciences, actively invest in Research and Development, contributing to the steady introduction of innovative heart devices that align with the growing demand for safer and effective cardiovascular interventions.

### **Government Initiatives and Funding for Healthcare Improvement**

Government initiatives aimed at improving healthcare infrastructure and patient care in Spain are expected to drive the Spain Structural Heart Devices Market Industry significantly. The Spanish government has launched various healthcare plans emphasizing better heart health, aiming for a 20% reduction in cardiovascular-related hospitalizations by 2025. Funding allocated for public hospitals and clinics has increased considerably, with more than 1 billion Euros redirected towards cardiovascular disease management programs.This progressive approach not only enhances healthcare quality but also stimulates market growth by promoting the adoption of advanced structural heart devices across facilities in Spain.

### **Rising Awareness and Early Diagnosis of Heart Conditions**

Rising awareness and early diagnosis of heart conditions among the Spanish population is a significant factor fueling growth in the Spain Structural Heart Devices Market Industry. Health campaigns and educational programs implemented by associations like the Spanish Heart Foundation have heightened public consciousness regarding heart health. Research indicates that an early diagnosis can lead to a 70% improvement in treatment outcomes. Consequently, with greater public engagement and proactive healthcare-seeking behavior, more individuals are being diagnosed earlier, resulting in an increased demand for advanced structural heart devices to address these conditions effectively.

## **Spain Structural Heart Devices Market Segment Insights****:**

### **Structural Heart Devices Market Type Insights**

The Spain Structural Heart Devices Market is experiencing significant growth, particularly within the Type segmentation that includes Heart Valve Devices, Annuloplasty Rings, Occluders, and Delivery Systems, all crucial components for the treatment of structural heart diseases are prevalent in the aging population. Heart Valve Devices play a central role as they are essential for patients suffering from valve diseases. They provide significant therapeutic options, contributing to improved survival rates and quality of life. 

Meanwhile, Annuloplasty Rings are instrumental in the repair of dysfunctional valve rings, helping to restore normal heart function and reduce the risks of heart failure. Occluders provide minimally invasive solutions for various structural heart defects such as atrial septal defects, presenting significant advantages in terms of recovery time and patient comfort, which is becoming increasingly relevant in contemporary healthcare settings in Spain.

Delivery Systems are another pivotal element, as they facilitate the accurate and safe deployment of these devices during minimally invasive procedures. The entire Type segmentation is uniquely positioned to benefit from the growing awareness of structural heart diseases and advancements in interventional cardiology techniques, which are further fueled by government-led initiatives aimed at enhancing healthcare accessibility in Spain. 

Over recent years, there has been a noticeable shift towards outpatient procedures, leading to an increase in the use of minimally invasive devices, thereby driving the demand across the mentioned types. Additionally, the rise in funding for medical device research and development in Spain is leading to the introduction of innovative solutions that enhance procedural efficacy and patient outcomes. With a significant rise in geriatric patients and an increase in lifestyle-related conditions like obesity and diabetes affecting heart health, the Spain Structural Heart Devices Market is presented with various opportunities for sustained growth.

Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review

### **Structural Heart Devices Market Indication Insights**

The Spain Structural Heart Devices Market, focusing on the Indication segment, is characterized by its significant divisions catering to various cardiovascular conditions, notably Valvular Heart Disease and Cardiomyopathy. Valvular Heart Disease represents a critical area within this market, as it often leads to serious health complications, necessitating effective intervention strategies and innovative device solutions. 

This condition has become increasingly prevalent, driving the demand for advanced heart devices. Meanwhile, Cardiomyopathy, which encompasses a range of diseases that affect the heart muscle, is another important classification within the Indication segment.It has garnered substantial attention as it requires specialized treatments to enhance patient outcomes. The growing elderly population in Spain is anticipated to further fuel the market's expansion in these specific areas. 

Additionally, increasing awareness regarding heart diseases and the advancements in medical technology are expected to support the development and adoption of improved treatment methodologies. As healthcare professionals prioritize patient-centric approaches, there lies a promising opportunity for growth in the Spain Structural Heart Devices Market, making it essential for stakeholders to focus on these key segments for future innovations and market positioning.

### **Structural Heart Devices Market Procedure Insights**

The Procedure segment of the Spain Structural Heart Devices Market is critical, reflecting the growing need for advanced medical interventions in treating heart conditions. Replacement Procedures and Repair Procedures play pivotal roles in this market, catering to diverse patient needs and conditions. 

Replacement Procedures often involve the surgical or catheter-based replacement of dysfunctional heart valves, addressing serious conditions that can arise from heart disease, which is prevalent in Spain due to its aging population and lifestyle factors.Conversely, Repair Procedures, which aim to fix structurally deficient heart valves without replacing them, are gaining traction as they are less invasive and often lead to quicker recovery times. 

The Spanish healthcare system has increasingly recognized the necessity for these advanced techniques, thus driving innovation and adoption in this area. Furthermore, government initiatives aimed at improving cardiovascular health highlight the significance of these procedures. As the Spain Structural Heart Devices Market continues to evolve, these offerings not only reflect technological advancements but also the urgent need for effective solutions to heart-related ailments, positioning the country as a key player in the cardiovascular devices industry within Europe.

## **Spain Structural Heart Devices Market Key Players and Competitive Insights****:**

The Spain Structural Heart Devices Market is witnessing significant advancements and competition due to the rising prevalence of cardiovascular diseases and the increasing healthcare expenditure by the government and private sectors. This market is characterized by a wide range of products including heart valves, closure devices, and other structural heart solutions designed to address various heart conditions effectively. 

Companies operating in this space are focusing on innovation, enhancing their product portfolios, and expanding their geographical presence to cater to the growing demand for minimally invasive procedures. The competitive landscape is dynamic, with several established players and emerging companies vying for market share, leading to a continuous evolution of product offerings and improved patient outcomes.Medtronic holds a prominent position in the Spain Structural Heart Devices Market, leveraging its strong brand reputation and extensive experience in the cardiovascular domain. 

The company’s strengths lie in its innovative technology and comprehensive product range, which includes advanced heart valves and repair devices. Medtronic has established a robust distribution network in Spain, ensuring accessibility and support for healthcare professionals and patients alike. The company also invests heavily in research and development to maintain its competitive edge, aligning its offerings with the latest clinical needs and technological advancements. 

Medtronic's commitment to improving patient outcomes, along with its strategic partnerships and collaborations within the Spanish healthcare ecosystem, further solidifies its leading role in the market.Micro Interventional Devices is also an important player in the Spain Structural Heart Devices Market, specializing in innovative solutions for structural heart conditions. The company focuses on the development of cutting-edge devices including treatments for aortic and mitral valve conditions. With a strong emphasis on minimally invasive techniques, Micro Interventional Devices enhances patient recovery experiences and outcomes. 

Its market presence in Spain is supported by strategic partnerships and collaborations with hospitals and healthcare systems, which facilitate the adoption of its technologies. The company’s strengths lie in its ability to quickly adapt to market dynamics and respond to unmet clinical needs, leading to effective product launches. Micro Interventional Devices continues to pursue growth opportunities through potential mergers and acquisitions aimed at expanding its product portfolio and enhancing its capabilities within the structural heart domain in Spain.

### **Key Companies in the Spain Structural Heart Devices Market Include:**

- Medtronic
- Micro Interventional Devices
- AtriCure
- Neovasc
- Corindus Vascular Robotics
- HeartWare International
- Sahajanand Medical Technologies
- Boston Scientific
- Abbott
- LivaNova
- Cardiosolutions
- Terumo Corporation
- JenaValve Technology
- Edwards Lifesciences

## **Spain Structural Heart Devices Market Industry Developments**

_The Spain Structural Heart Devices Market has seen notable developments recently, particularly with companies such as Medtronic, Boston Scientific, and Abbott, which are enhancing their product offerings. In August 2023, Medtronic launched new transcatheter mitral valve replacement solutions in Spain, aiming to address the growing prevalence of heart diseases in the region. Additionally, in July 2023, Edwards Lifesciences announced a strategic partnership with local hospitals to facilitate innovative clinical trials for their heart valve technologies. _

AtriCure has also made advancements by introducing improved surgical device platforms tailored to Spanish healthcare needs. Furthermore, in September 2023, there were talks of potential collaborations between JenaValve Technology and Neovasc to streamline distribution channels within Spain. Regarding mergers and acquisitions, in June 2023, LivaNova acquired a leading Spanish surgical company specializing in cardiac devices to expand its market reach. This acquisition reflects an ongoing trend of consolidation in the market aimed at enhancing product portfolios and improving patient outcomes.

Overall, the Spanish market is poised for growth, driven by increasing investments in research and development and rising awareness of structural heart conditions among the population.

## **Spain Structural Heart Devices Market Segmentation Insights**

### **Structural Heart Devices Market Type****Outlook**

- Heart Valve Devices
- Annuloplasty Rings
- Occluders
- Delivery Systems

### **Structural Heart Devices Market Indication****Outlook**

- Valvular Heart Disease
- Cardiomyopathy

### **Structural Heart Devices Market Procedure****Outlook**

- Replacement Procedures
- Repair Procedures

## Market Drivers

### Supportive Regulatory Environment

The regulatory landscape in Spain is becoming increasingly supportive of the structural heart-devices market. Recent initiatives by health authorities aim to streamline the approval process for innovative medical devices, thereby facilitating quicker access to the market. This regulatory support is crucial for manufacturers looking to introduce new products, as it reduces the time and costs associated with bringing devices to market. Additionally, reimbursement policies are evolving to cover a broader range of structural heart devices, making them more accessible to patients. As the regulatory environment continues to improve, it is likely to encourage investment and innovation within the structural heart-devices market, ultimately benefiting patient care.

### Investment in Healthcare Infrastructure

Spain's commitment to enhancing its healthcare infrastructure significantly impacts the structural heart-devices market. The government has allocated substantial funding to improve hospital facilities and expand access to advanced medical technologies. This investment is expected to facilitate the adoption of innovative structural heart devices, as hospitals become better equipped to perform complex procedures. Additionally, the establishment of specialized cardiac centers across the country is likely to increase the availability of these devices, making them more accessible to patients. With an estimated €1.5 billion earmarked for healthcare improvements in the coming years, the structural heart-devices market is poised for growth as healthcare providers adopt cutting-edge technologies to meet patient needs.

### Growing Awareness and Education Initiatives

The increasing awareness of heart health and the importance of early intervention is driving the structural heart-devices market in Spain. Educational campaigns aimed at both healthcare professionals and the general public are crucial in promoting the benefits of these devices. As more individuals become informed about the risks associated with untreated structural heart conditions, the demand for timely diagnosis and treatment options is likely to rise. Furthermore, training programs for healthcare providers on the latest advancements in structural heart devices are essential for ensuring proper implementation and patient care. This heightened awareness and education are expected to contribute positively to the growth of the structural heart-devices market, as patients seek out these innovative solutions.

### Increasing Prevalence of Cardiovascular Diseases

The rising incidence of cardiovascular diseases in Spain is a primary driver for the structural heart-devices market. According to recent health statistics, cardiovascular diseases account for approximately 30% of all deaths in the country. This alarming trend necessitates advanced treatment options, including structural heart devices, to manage conditions such as heart valve disorders and congenital heart defects. The growing awareness among healthcare professionals and patients regarding the benefits of these devices is likely to further stimulate market growth. As the population ages, the demand for effective interventions is expected to increase, thereby propelling the structural heart-devices market forward. Furthermore, the integration of these devices into standard treatment protocols may enhance patient outcomes, making them a preferred choice for both physicians and patients alike.

### Technological Innovations in Device Functionality

Technological advancements in the functionality of structural heart devices are a significant driver of market growth in Spain. Innovations such as bioresorbable materials, advanced imaging techniques, and improved delivery systems enhance the effectiveness and safety of these devices. The introduction of devices that can be implanted with minimal invasiveness is particularly appealing to both patients and healthcare providers. As these technologies evolve, they are likely to expand the range of treatable conditions, thereby increasing the overall market potential. The structural heart-devices market is expected to benefit from ongoing research and development efforts, which aim to create devices that offer better outcomes and reduced recovery times for patients.

## Future Outlook

The [Structural Heart Devices Market](https://www.marketresearchfuture.com/reports/structural-heart-devices-market-6385) in Spain is projected to grow at a 5.86% CAGR from 2025 to 2035, driven by technological advancements and increasing patient demand.

**New opportunities:**

- Development of minimally invasive surgical techniques for heart valve repair.
- Expansion of telehealth services for remote patient monitoring and follow-up.
- Investment in R&D for innovative biomaterials in device manufacturing.

By 2035, the market is expected to achieve substantial growth, reflecting evolving healthcare needs.

## Segment Insights

### By Type: Transcatheter Aortic Valve Replacement (Largest) vs. Mitral Valve Repair Devices (Fastest-Growing)

In the Spain structural heart-devices market, the segment values exhibit a varied distribution in terms of market share. Transcatheter Aortic Valve Replacement devices lead as the largest segment due to their widespread adoption in treating aortic stenosis. In contrast, Mitral Valve Repair Devices are experiencing robust growth, fueled by increasing prevalence of mitral valve disorders and advancements in minimally invasive surgical techniques.

Growth trends in this segment indicate a surge in demand for innovative solutions that enhance patient outcomes. Factors driving this growth include an aging population, rising awareness of heart diseases, and increased acceptance of transcatheter procedures. As healthcare providers aim for more effective treatments with shorter recovery times, Mitral Valve Repair Devices are positioned as the fastest-growing option within the segment, reflecting the shift in procedural preference among cardiologists.

Transcatheter Aortic Valve Replacement (Dominant) vs. Mitral Valve Repair Devices (Emerging)

Transcatheter Aortic Valve Replacement (TAVR) devices are currently dominant in the Spain structural heart-devices market, primarily due to their effectiveness in treating severe aortic stenosis in high-risk patients. These devices allow for a minimally invasive approach, significantly reducing patient recovery times and improving overall outcomes. On the other hand, Mitral Valve Repair Devices are emerging rapidly, driven by innovative developments that support effective repair of mitral valve regurgitation. The adoption of these devices is bolstered by the growing interest in less invasive options, aligning with the medical community's ongoing efforts to enhance patient care through technology. Both segments showcase distinct characteristics, catering to specific cardiovascular conditions while reflecting broader trends towards patient-centered treatment pathways.

### By Procedure Type: Minimally Invasive (Largest) vs. Surgical (Fastest-Growing)

In the Spain structural heart-devices market, the segment shares are primarily dominated by Minimally Invasive procedures, which have garnered the largest market share due to their favorable outcomes and reduced recovery times. Surgical methods hold a significant position as well, but they are gradually facing stiff competition from newer, less invasive techniques. This shift reflects the changing preferences of both patients and healthcare providers in seeking more efficient treatment options. 

Analyzing growth trends, the Minimally Invasive segment continues to lead, benefiting from advancements in technology and techniques. Meanwhile, the Surgical segment is emerging as the fastest-growing area in response to increasing healthcare investments and the rising prevalence of complex heart conditions requiring surgical intervention. The growing awareness and acceptance of these procedures are driving the market's expansion.

Minimally Invasive (Dominant) vs. Surgical (Emerging)

The Minimally Invasive procedure segment is characterized by its ability to provide effective treatment while minimizing patient trauma and recovery times, making it increasingly popular among both patients and healthcare professionals. This segment leverages advanced technologies such as robotic assistance and innovative catheter-based techniques to enhance precision and reduce complications. Conversely, the Surgical segment, although historically mainstream, is adapting to increasing demand by integrating minimally invasive methodologies. This shift enables traditional surgical practices to retain relevance in an evolving landscape while meeting the needs of patients requiring more extensive interventions. Together, these segments illustrate a dynamic market driven by technological innovation and changing patient expectations.

### By Indication: Aortic Stenosis (Largest) vs. Mitral Regurgitation (Fastest-Growing)

In the Spain structural heart-devices market, Aortic Stenosis holds the largest market share among the indications, reflecting a significant demand for effective treatment options. Mitral Regurgitation is emerging as a key player in terms of growth, capturing the attention of providers and patients alike as awareness of its implications increases. The combined focus on these conditions needs to be addressed with innovations in device solutions to cater to both existing and emerging needs.  

Growth trends indicate a robust upward trajectory for the Mitral Regurgitation segment, driven by a rising aging population and an increase in the prevalence of heart diseases. The adoption of advanced treatment methodologies and the introduction of innovative devices are powering this momentum. Furthermore, an enhanced emphasis on preventative care and early diagnosis is expected to further propel the growth of the structural heart-devices market across these indications.

Aortic Stenosis (Dominant) vs. Mitral Regurgitation (Emerging)

Aortic Stenosis is the dominant indication in the Spain structural heart-devices market, characterized by a well-established treatment pathway and extensive clinical familiarity with available devices. This segment benefits from a robust clinical framework and established technology, making it a preferred option for both patients and providers. In contrast, Mitral Regurgitation is emerging rapidly due to its growing recognition as a prevalent cardiac condition with substantial patient burden. This segment showcases an increasing number of innovative therapies, capturing a more significant market share as new devices enter the landscape, appealing to patients seeking options with fewer complications. Together, these segments highlight the diverse needs and emerging opportunities within the structural heart-devices market.

### By End User: Hospitals (Largest) vs. Cardiology Clinics (Fastest-Growing)

In the Spain structural heart-devices market, Hospitals dominate the end-user segment, currently accounting for the majority share due to their extensive infrastructure, specialized staff, and advanced technology. Ambulatory Surgical Centers are also significant but hold a smaller share as they cater to outpatient procedures, whereas Cardiology Clinics, despite being smaller, are witnessing rapid growth as they focus on heart-specific treatments that enhance patient care.

The growth trends within the end-user segment indicate a rising demand for specialized cardiac care driven by an increasing prevalence of heart diseases and advancements in minimally invasive surgical techniques. Hospitals are enhancing their capabilities with the adoption of cutting-edge technologies. In contrast, Cardiology Clinics are emerging as vital centers for preventive care and diagnostics, expected to grow rapidly as they adapt to evolving patient needs and new healthcare models.

Hospitals (Dominant) vs. Cardiology Clinics (Emerging)

Hospitals play a dominant role in the Spain structural heart-devices market due to their extensive resources, comprehensive service offerings, and access to the latest technologies that enable complex cardiovascular procedures. They have established partnerships with device manufacturers, ensuring a steady supply of advanced structural heart devices. On the other hand, Cardiology Clinics are an emerging segment, benefiting from their specialized focus on cardiovascular conditions, attracting an increasing patient base looking for targeted interventions. These clinics are rapidly adopting innovative devices to provide superior care and improve patient outcomes, positioning themselves as integral players in the overall ecosystem, particularly for outpatient cardiac assessments and treatments.

## Competitive Benchmarking

The structural heart-devices market in Spain is characterized by a dynamic competitive landscape, driven by technological advancements and an increasing prevalence of cardiovascular diseases. Key players such as Edwards Lifesciences (US), Medtronic (US), and Abbott Laboratories (US) are at the forefront, focusing on innovation and strategic partnerships to enhance their market presence. Edwards Lifesciences (US) emphasizes its commitment to research and development, particularly in transcatheter heart valves, which positions it favorably against competitors. Medtronic (US) leverages its extensive portfolio and global reach, while Abbott Laboratories (US) is concentrating on expanding its minimally invasive solutions, thereby shaping a competitive environment that prioritizes advanced therapeutic options.
The market structure appears moderately fragmented, with several players vying for market share. Key business tactics include localizing manufacturing to reduce costs and optimize supply chains, which is crucial in maintaining competitive pricing. The collective influence of these major companies fosters a competitive atmosphere where innovation and operational efficiency are paramount, allowing them to respond swiftly to market demands and regulatory changes.
In October 2025, Medtronic (US) announced the launch of its latest transcatheter aortic valve replacement (TAVR) system, which integrates advanced imaging technology to enhance procedural outcomes. This strategic move is likely to solidify Medtronic's position in the market, as it addresses the growing demand for less invasive surgical options, thereby appealing to both healthcare providers and patients seeking improved recovery times.
In September 2025, Abbott Laboratories (US) expanded its partnership with a leading Spanish hospital network to enhance the adoption of its heart valve technologies. This collaboration is significant as it not only increases Abbott's market penetration but also aligns with the growing trend of personalized medicine, allowing for tailored treatment options that could improve patient outcomes.
In August 2025, Edwards Lifesciences (US) secured a strategic alliance with a prominent research institution in Spain to advance the development of next-generation heart valve therapies. This partnership underscores the importance of innovation in the competitive landscape, as it enables Edwards to leverage cutting-edge research to enhance its product offerings and maintain a competitive edge.
As of November 2025, the competitive trends in the structural heart-devices market are increasingly defined by digitalization, sustainability, and the integration of artificial intelligence (AI) in product development and patient management. Strategic alliances are becoming more prevalent, facilitating knowledge sharing and resource optimization among key players. Looking ahead, the competitive differentiation is expected to evolve, shifting from traditional price-based competition to a focus on innovation, technological advancements, and supply chain reliability, which will be critical in meeting the demands of a rapidly changing healthcare environment.

## Recent News & Developments

_The Spain Structural Heart Devices Market has seen notable developments recently, particularly with companies such as Medtronic, Boston Scientific, and Abbott, which are enhancing their product offerings. In August 2023, Medtronic launched new transcatheter mitral valve replacement solutions in Spain, aiming to address the growing prevalence of heart diseases in the region. Additionally, in July 2023, Edwards Lifesciences announced a strategic partnership with local hospitals to facilitate innovative clinical trials for their heart valve technologies. _

AtriCure has also made advancements by introducing improved surgical device platforms tailored to Spanish healthcare needs. Furthermore, in September 2023, there were talks of potential collaborations between JenaValve Technology and Neovasc to streamline distribution channels within Spain. Regarding mergers and acquisitions, in June 2023, LivaNova acquired a leading Spanish surgical company specializing in cardiac devices to expand its market reach. This acquisition reflects an ongoing trend of consolidation in the market aimed at enhancing product portfolios and improving patient outcomes.

Overall, the Spanish market is poised for growth, driven by increasing investments in research and development and rising awareness of structural heart conditions among the population.

## Report Scope

| MARKET SIZE 2024 | 19.25(USD Million) |
| --- | --- |
| MARKET SIZE 2025 | 20.38(USD Million) |
| MARKET SIZE 2035 | 36.0(USD Million) |
| COMPOUND ANNUAL GROWTH RATE (CAGR) | 5.86% (2025 - 2035) |
| REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| BASE YEAR | 2024 |
| Market Forecast Period | 2025 - 2035 |
| Historical Data | 2019 - 2024 |
| Market Forecast Units | USD Million |
| Key Companies Profiled | Edwards Lifesciences (US), Medtronic (US), Abbott Laboratories (US), Boston Scientific (US), Cardinal Health (US), LivaNova (GB), Terumo Corporation (JP), JenaValve Technology (DE), AtriCure (US) |
| Segments Covered | Type, Procedure Type, Indication, End User |
| Key Market Opportunities | Advancements in minimally invasive procedures enhance growth potential in the structural heart-devices market. |
| Key Market Dynamics | Rising demand for minimally invasive procedures drives innovation in structural heart-devices within Spain's healthcare sector. |
| Countries Covered | Spain |

## Frequently Asked Questions

**Q: What is the current valuation of the structural heart-devices market in Spain as of 2024?**
A: The market valuation was $19.25 Million in 2024.

**Q: What is the projected market size for structural heart-devices in Spain by 2035?**
A: The projected valuation for 2035 is $36.0 Million.

**Q: What is the expected CAGR for the Spain structural heart-devices market during the forecast period 2025 - 2035?**
A: The expected CAGR is 5.86% during the forecast period 2025 - 2035.

**Q: Which companies are the key players in the Spain structural heart-devices market?**
A: Key players include Edwards Lifesciences, Medtronic, Abbott Laboratories, Boston Scientific, and others.

**Q: What are the main segments of the structural heart-devices market in Spain?**
A: The main segments include Type, Procedure Type, Indication, and End User.

**Q: How did the Transcatheter Aortic Valve Replacement segment perform in 2024?**
A: This segment had a valuation ranging from $5.0 Million to $9.0 Million in 2024.

**Q: What is the valuation range for Mitral Valve Repair Devices in 2024?**
A: The valuation for Mitral Valve Repair Devices ranged from $4.5 Million to $8.0 Million in 2024.

**Q: Which end user segment had the highest valuation in 2024?**
A: Hospitals had the highest valuation, ranging from $8.0 Million to $15.0 Million in 2024.

**Q: What is the projected growth for the Left Atrial Appendage Closure Devices segment by 2035?**
A: This segment is expected to grow, with a valuation range projected between $3.0 Million and $6.0 Million.

**Q: What indications are driving the growth of the structural heart-devices market in Spain?**
A: Key indications include Aortic Stenosis, Mitral Regurgitation, and Heart Failure.


---

*This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/spain-structural-heart-devices-market-56910*